Rewalk Robotics (Nasdaq: RWLK) today reported its third-quarter revenues were half what they were a year before, with losses widening. However, the robotic exoskeletons company is seeking to advance its technology through reimbursement wins in the U.S. and Germany. Early this month, Rewalk submitted its first case to Medicare Administrative Contractors (MACs) for coverage and […]
NeuroMetrix strategically launches Quell Fibromyalgia
NeuroMetrix (Nasdaq: NURO) announced the strategic launch of its Quell Fibromyalgia device through its Pathfinder Program. The move — announced yesterday — comes nearly 6 months after NeuroMetrix said it had received an FDA de novo authorization to use its Quell neuromodulation device to treat fibromyalgia symptoms. The Pathfinder Program starts Dec. 1. NeuroMetrix limited […]
Outset Medical secures debt financing of up to $300M
Outset Medical (Nasdaq: OM) today announced two senior secured credit facilities with investment affiliates managed by SLR Capital Partners. Collectively, the facilities provide for up to $300 million in borrowing for the maker of the Tablo Hemodialysis System. The facilities include an up-to-$250-million term loan facility and an up-to-$50-million asset-based revolving credit facility. Outset drew $100 […]
Cardinal Health beats The Street in Q1 — but takes a hit on PPE
Cardinal Health (NYSE: CAH) today reported first-quarter results that beat the consensus forecast on Wall Street, sticking by its full-year EPS guidance. The Dublin, Ohio–based pharma and medtech giant earned $110 million, or 40¢ per share, off $49.6 billion in revenue for the quarter ended Sept. 30, 2022. The bottom line was less than half […]
Dentsply Sirona says former top execs didn’t intentionally do wrong
Dentsply Sirona (Nasdaq: XRAY) announced today that its board’s audit committee found no evidence of intentional wrongdoing or fraud on the part of its former CEO or CFO. The dental tech company fired former CEO Don Casey in April. Previous CFO Jorge Gomez soon left his new job at Moderna. Former BD executive Simon Campion is now […]
Stryker earnings miss in Q3 amid high key component prices
Stryker (NYSE:SYK) reported third-quarter results that beat the Wall Street revenue consensus but missed on earnings, reducing its full-year EPS guidance. Investors reacted by sending SYK shares down more than 4% to $219.87 apiece by afternoon trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up more than […]
Edwards Lifesciences misses in Q3 amid economic challenges
Edwards Lifesciences (NYSE: EW) shares are down today — a day after reporting third-quarter results that missed the Wall Street consensus forecast. EW shares were down more than 18% to $70.49 apiece by the afternoon today. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down more […]
ResMed powers through supply chain challenges in Q1
ResMed (NYSE: RMD, ASX: RMD) reported first-quarter results that beat The Street on revenue but missed by a penny on earnings per share. CEO Mick Farrell yesterday evening expressed confidence that ResMed’s suppliers will enable the maker of sleep therapy tech such as CPAPs to steadily increase production through the fiscal year. Farrell got to […]
Integer Q3 results mixed amid supply chain challenges
Integer Holdings (NYSE:ITGR) today reported third-quarter results that beat The Street on earnings but missed on revenue amid continued supply chain challenges. The Plano, Texas–based medtech contract manufacturing giant had already warned investors early this month. It reported that deteriorating delivery performance and missed commitments from three suppliers would impact Q3 sales by $15 million. […]
BD secures ISO certification for its information security management system
BD announced today that it has secured ISO certification for its enterprise-level Information Security Management System. The Franklin Lakes, New Jersey–based company said the ISMS meets a rigorous set of independently audited international standards. BD says the ISO/IEC 27001:2022 certification demonstrates its commitment to protecting the company, customers and patients from cybersecurity threats. The International […]
Boston Scientific reports mixed Q3 results amid challenging economic environment
Boston Scientific (NYSE: BSX) today reported third-quarter revenue that beat the consensus forecast on Wall Street, but it missed by a penny on earnings. The Marlborough, Massachusetts–based interventional medical devices giant also reduced its full-year adjusted EPS outlook amid a challenging macroeconomic environment. A host of medical device companies are facing the effects of a […]